Peter Emtage

Peter Emtage

Chief Executive Officer at Santa Ana Bio, Inc.

Health Technology
Consumer Services
Finance

Profile

Peter Emtage is currently the Chief Executive Officer & Director at Santa Ana Bio, Inc. and a Venture Partner at Versant Venture Management LLC.
Previously, he worked as a Director at Kyverna Therapeutics, Inc., Vice President-Immunotherapy at MedImmune LLC, Vice President-Research & Development at Nventa Biopharmaceuticals Corp., Vice President-Synthetic Immunology at Precigen, Inc., and Chief Scientific Officer at Femta Pharmaceuticals, Inc. He received his undergraduate and graduate degrees from the University of Guelph and his doctorate from McMaster University.

Peter Emtage active positions

CompaniesPositionStart
Private Equity Investor 31/03/2021
Chief Executive Officer -
All active positions of Peter Emtage

Former positions of Peter Emtage

CompaniesPositionEnd
KYVERNA THERAPEUTICS, INC. Director/Board Member 25/01/2022
Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
PRECIGEN, INC. Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
See the detail of Peter Emtage's experience

Training of Peter Emtage

University of Guelph Graduate Degree
McMaster University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Emtage's experience

Connections

37

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
PRECIGEN, INC.

Health Technology

KYVERNA THERAPEUTICS, INC.

Health Technology

Private companies5

Health Technology

Health Technology

Finance

Health Technology

Health Technology

See company connections